Resources

In a diagnostic clinical pathology laboratory, a technologist performs differential Gram staining followed by fluorescence in situ hybridization (FISH) on a synovial fluid aspirate from a patient with acute septic arthritis. The sample contains two cell populations: Host Inflammatory Cells (Population XX) and Microbial Pathogens (Population YY). Cell population XX averages 12  μm12\;\mu\text{m} to 15  μm15\;\mu\text{m} in diameter and shows multiple internal fluorophore-labeled 18 S18\text{ S} rRNA puncta localized in the cytosol, bounded by an intact actin cytoskeleton. Cell population YY averages 0.8  μm0.8\;\mu\text{m} in diameter, stains Gram-positive purple, and binds specific 16 S16\text{ S} rRNA oligonucleotide probes uniformly throughout its interior without compartmental partitioning. Categorize Population XX and Population YY as prokaryotic or eukaryotic, and explain why an antibiotic targeting the peptidoglycan cross-linking enzyme transpeptidase eliminates Population YY with zero mechanism-based cytotoxicity to Population XX.

Answer and steps

Final answer

Population XX is eukaryotic (human neutrophils/leukocytes); Population YY is prokaryotic (Gram-positive bacteria). Transpeptidase-inhibiting antibiotics (such as β\beta-lactams) exhibit selective toxicity because peptidoglycan and bacterial D-alanyl-D-alanine transpeptidases are strictly unique to prokaryotic cell wall synthesis and completely absent in eukaryotic human cells, which lack cell walls.

Steps

01

Categorize Population XX Based on Structural and Molecular Markers

  • Size and Cytoskeleton: Population XX has a diameter of 12–15  μm12\text{--}15\;\mu\text{m} and contains an organized internal actin cytoskeleton. Typical eukaryotic animal cells range from 10–100  μm10\text{--}100\;\mu\text{m}, whereas prokaryotes are generally much smaller (0.2–2.0  μm0.2\text{--}2.0\;\mu\text{m}).
  • Ribosomal RNA Subunit: Population XX displays 18 S18\text{ S} ribosomal RNA (rRNA). The 18 S18\text{ S} rRNA is the signature structural RNA of the small (40 S40\text{ S}) ribosomal subunit of eukaryotes (part of the complete 80 S80\text{ S} ribosome).

Therefore, Population XX is eukaryotic (representing host inflammatory cells, such as neutrophils/leukocytes).


02

Categorize Population YY Based on Structural and Molecular Markers

  • Size and Morphology: Population YY averages 0.8  μm0.8\;\mu\text{m} in diameter and lacks compartmentalized internal organelles.
  • Cell Wall Characteristics: It retains Gram-positive crystal violet-iodine complexes (staining purple), indicating a thick, exterior meshwork of peptidoglycan.
  • Ribosomal RNA Subunit: Population YY hybridizes with probes against 16 S16\text{ S} rRNA distributed uniformly throughout the cytoplasm. The 16 S16\text{ S} rRNA is a hallmark of the small (30 S30\text{ S}) ribosomal subunit of prokaryotes (part of the complete 70 S70\text{ S} ribosome).

Therefore, Population YY is prokaryotic (representing Gram-positive bacteria).


03

Explain the Basis of Selective Toxicity

  • Target Mechanism: Bacterial transpeptidases (also known as penicillin-binding proteins, or PBPs) catalyze the final cross-linking step of adjacent peptide side-chains (specifically between D-Ala\text{D-Ala} and D-Ala\text{D-Ala}/diaminopimelic acid or lysine) during peptidoglycan cell wall biosynthesis.
  • Antibiotic Action: β\beta-lactam antibiotics (such as penicillin or cephalosporin) mimic the D-Ala-D-Ala\text{D-Ala-D-Ala} terminal dipeptide, covalently binding and inactivating transpeptidase. This prevents cross-link formation, destabilizing the cell wall and causing osmotic lysis of actively dividing bacteria (Population YY).
  • Absence of Host Target: Animal eukaryotic cells (Population XX) do not possess a cell wall, nor do they synthesize peptidoglycan or express transpeptidase enzymes.

Because the molecular target is entirely absent in human host cells, the drug exhibits selective toxicity, killing Population YY while causing zero mechanism-based cytotoxicity to Population XX.

Typical errors

OverviewACEpath Teacher's Diagnosis

01 The student misidentifies ribosomal subunit types by associating 16S rRNA with eukaryotic ribosomes and 18S rRNA with prokaryotes, reversing the cellular categories.

Sample Student Work

Reviewed by ACEpath Teacher
Step-by-Step Review
Walk Through It with Your Teacher
Incorrect
  1. Step 1

    Population X contains 18S rRNA and is prokaryotic. Population Y contains 16S rRNA and is eukaryotic.

    Correct

    Population X contains 18 S18\text{ S} rRNA and is eukaryotic; Population Y contains 16 S16\text{ S} rRNA and is prokaryotic.

    You inverted the rRNA markers: 18 S18\text{ S} rRNA is the characteristic component of eukaryotic small (40 S40\text{ S}) ribosomal subunits, while 16 S16\text{ S} rRNA is specific to prokaryotic small (30 S30\text{ S}) ribosomal subunits.

  2. Step 2

    Transpeptidase forms peptidoglycan cross-links in the bacterial wall.

  3. Step 3

    Population X has a peptidoglycan wall and is eliminated by the drug, while Population Y lacks peptidoglycan.

    Correct

    Population Y has a peptidoglycan cell wall and is eliminated by transpeptidase inhibitors, whereas eukaryotic Population X lacks peptidoglycan entirely, resulting in zero mechanism-based cytotoxicity.

    Because you reversed the cell identities in Step 1, you incorrectly assigned the peptidoglycan cell wall and drug susceptibility to Population X instead of Population Y.

WHAT YOU DID WELL
Compliments from Your Teacher

You correctly stated the biochemical role of transpeptidase in cross-linking bacterial peptidoglycan.

THE ERROR
Where Your ACEpath Teacher Spotted the Mistake
Reversal of prokaryotic and eukaryotic rRNA markers

You associated 18 S18\text{ S} rRNA with prokaryotes and 16 S16\text{ S} rRNA with eukaryotes, reversing the cellular categories.

WHY IT HAPPENED
ACEpath Teacher's Diagnosis

You confused the structural RNA components of prokaryotic 70 S70\text{ S} ribosomes (16 S16\text{ S} small subunit) with eukaryotic 80 S80\text{ S} ribosomes (18 S18\text{ S} small subunit).

REASONING PATH
Your ACEpath teacher’s suggested approach
Ribosomal Subunit Markers
  • Prokaryotic ribosomes (70 S70\text{ S}) contain a 30 S30\text{ S} small subunit harboring 16 S16\text{ S} rRNA. Eukaryotic cytoplasmic ribosomes (80 S80\text{ S}) contain a 40 S40\text{ S} small subunit harboring 18 S18\text{ S} rRNA.

  • Always pair 16 S16\text{ S} rRNA with prokaryotes/bacteria and 18 S18\text{ S} rRNA with eukaryotes.

Corroborating Morphological Criteria
  • Eukaryotic cells are generally larger (10–100  μm10\text{--}100\;\mu\text{m}) and possess an internal actin cytoskeleton. Prokaryotes are smaller (0.2–2.0  μm0.2\text{--}2.0\;\mu\text{m}) and Gram stain according to their peptidoglycan wall.

  • Cross-check molecular markers with cell diameter (12–15  μm12\text{--}15\;\mu\text{m} for X vs 0.8  μm0.8\;\mu\text{m} for Y) to verify your classification.

CORRECTED PATH
ACEpath Teacher's Demonstration
  1. Identify Population X (12–15  μm12\text{--}15\;\mu\text{m}, actin cytoskeleton, 18 S18\text{ S} rRNA) as eukaryotic.

  2. Identify Population Y (0.8  μm0.8\;\mu\text{m}, Gram-positive, 16 S16\text{ S} rRNA) as prokaryotic.

  3. Connect the drug mechanism: transpeptidase inhibitors selectively disrupt peptidoglycan cross-linking in prokaryotic walls (Population Y), sparing eukaryotic cells (Population X) which lack peptidoglycan entirely.

Final answer

Population X is eukaryotic; Population Y is prokaryotic. The transpeptidase inhibitor specifically destroys Population Y because peptidoglycan cell walls are unique to prokaryotes and completely absent in eukaryotic host cells.

NEXT STEPS
Final Takeaways from Your Teacher
  • Review the structural components of 70 S70\text{ S} versus 80 S80\text{ S} ribosomes, focusing on their respective rRNA subunits (16 S16\text{ S} vs 18 S18\text{ S}).

  • Practice using cell size and internal cytoskeletal features as sanity checks when categorizing unknown cell populations.

OverviewACEpath Teacher's Diagnosis

02 The student believes all cells contain peptidoglycan and assumes selective toxicity is due to differences in antibiotic transport or cell membrane permeability rather than the absence of the peptidoglycan target in eukaryotes.

Sample Student Work

Reviewed by ACEpath Teacher
Step-by-Step Review
Walk Through It with Your Teacher
Partially correct
  1. Step 1

    Population XX is eukaryotic due to 18 S18\text{ S} rRNA and cytoskeletal structure. ⟹\Longrightarrow Population YY is prokaryotic due to 16 S16\text{ S} rRNA and Gram-positive staining.

  2. Step 2

    Inhibiting transpeptidase prevents peptidoglycan synthesis in the wall.

  3. Step 3

    Population YY takes up the antibiotic directly across its porous wall, whereas the eukaryotic plasma membrane of Population XX blocks the antibiotic from reaching its peptidoglycan.

    Correct

    Eukaryotic host cells (Population XX) completely lack cell walls, peptidoglycan, and transpeptidase enzymes, so the drug has no molecular target in host cells.

    Your explanation relies on differential membrane permeability, assuming host cells have peptidoglycan. Eukaryotic animal cells do not possess peptidoglycan or cell walls at all, which is the true basis for selective toxicity.

WHAT YOU DID WELL
Compliments from Your Teacher

You correctly classified Population XX as eukaryotic based on 18 S18\text{ S} rRNA and an actin cytoskeleton.

You correctly classified Population YY as prokaryotic based on 16 S16\text{ S} rRNA and Gram-positive staining.

You identified that transpeptidase functions in peptidoglycan synthesis.

THE ERROR
Where Your ACEpath Teacher Spotted the Mistake
Cell Wall Composition & Selective Toxicity Misconception

no

WHY IT HAPPENED
ACEpath Teacher's Diagnosis

You assumed that peptidoglycan is a universal cellular component present inside eukaryotic cells, attributing selective toxicity to differential membrane permeability rather than the complete absence of the drug target (peptidoglycan and transpeptidase) in animal cells.

REASONING PATH
Your ACEpath teacher’s suggested approach
Peptidoglycan Distribution
  • Peptidoglycan is uniquely synthesized by bacteria; animal cells have no cell wall and never produce peptidoglycan or transpeptidase enzymes.

  • Attribute β\beta-lactam selective toxicity to target absence in host cells, not to transport or membrane permeability barriers.

CORRECTED PATH
ACEpath Teacher's Demonstration
  1. Recognize that human host cells (Population XX) are animal cells and possess only a plasma membrane without any peptidoglycan cell wall.

  2. Note that bacterial transpeptidases (penicillin-binding proteins) have no homologs or functional equivalents in human host cells.

  3. Conclude that because the molecular target is entirely absent from Population XX, transpeptidase inhibitors cause zero mechanism-based toxicity to host cells.

Final answer

Population XX is eukaryotic; Population YY is prokaryotic. Transpeptidase inhibitors selectively eliminate Population YY because peptidoglycan and transpeptidase are unique to bacterial cell wall biosynthesis and entirely absent in human eukaryotic cells.

NEXT STEPS
Final Takeaways from Your Teacher
  • Review the distinct structural differences between bacterial cell envelopes and animal cell membranes.

  • Practice answering pharmacology and cell biology questions by distinguishing between target absence versus pharmacokinetic exclusion.

OverviewACEpath Teacher's Diagnosis

03 The student confuses the mechanism of beta-lactam antibiotics targeting transpeptidase with translation inhibition at the ribosome.

Sample Student Work

Reviewed by ACEpath Teacher
Step-by-Step Review
Walk Through It with Your Teacher
Partially correct
  1. Step 1

    Population X is eukaryotic because it has 18S rRNA and cytoskeleton.

  2. Step 2

    Population Y is prokaryotic because it has 16S rRNA and lacks compartmentalization.

  3. Step 3

    The antibiotic binds to the 16S ribosomal subunit in Population Y to stop protein translation. ⟹\Longrightarrow Population X is unharmed because it uses 18S rRNA in its 80S ribosomes which cannot bind the drug.

    Correct

    Transpeptidase catalyzes the cross-linking of peptidoglycan side chains in bacterial cell wall synthesis (Population YY), and inhibiting it causes cell wall destabilization and osmotic lysis. Population XX is completely unaffected because human host cells lack cell walls and do not express peptidoglycan or transpeptidase enzymes.

    The prompt asked about an antibiotic targeting the cell wall enzyme transpeptidase, but you described an antibiotic that inhibits the 30 S30\text{ S} ribosomal subunit (16 S16\text{ S} rRNA).

WHAT YOU DID WELL
Compliments from Your Teacher

You correctly identified Population XX as eukaryotic based on 18 S18\text{ S} rRNA and an actin cytoskeleton.

You correctly identified Population YY as prokaryotic based on 16 S16\text{ S} rRNA and the absence of compartmentalization.

You understood the broad principle of selective toxicity between prokaryotic and eukaryotic molecular targets.

THE ERROR
Where Your ACEpath Teacher Spotted the Mistake
Antibiotic Mechanism Misidentification

no

WHY IT HAPPENED
ACEpath Teacher's Diagnosis

You confused cell-wall-inhibiting antibiotics (transpeptidase/penicillin-binding protein inhibitors such as β\beta-lactams) with protein synthesis inhibitors that target the bacterial 30 S30\text{ S} ribosomal subunit (such as aminoglycosides or tetracyclines).

REASONING PATH
Your ACEpath teacher’s suggested approach
Identify the Biochemical Target
  • Transpeptidases (PBPs) catalyze peptidoglycan transpeptidation in the bacterial cell wall, not protein translation at the ribosome.

  • Read the target enzyme specified in the prompt carefully before assigning an antibiotic mechanism of action.

Link Target to Selective Toxicity
  • Selective toxicity relies on the total absence of the drug's target structure or pathway in the host cell.

  • Explain selective toxicity by stating that eukaryotic animal cells completely lack a peptidoglycan cell wall and its biosynthetic enzymes.

CORRECTED PATH
ACEpath Teacher's Demonstration
  1. Identify the biochemical function of transpeptidase: it cross-links peptide chains between adjacent glycan polymers during peptidoglycan cell wall assembly.

  2. Determine the consequence of inhibition in Population YY: blocking cross-linking weakens the bacterial peptidoglycan envelope, leading to osmotic lysis and cell death.

  3. Determine why Population XX experiences zero mechanism-based cytotoxicity: eukaryotic host cells (human leukocytes) have no cell wall and synthesize zero peptidoglycan, meaning the molecular target is entirely absent.

Final answer

Population XX is eukaryotic; Population YY is prokaryotic. The antibiotic inhibits transpeptidase, preventing peptidoglycan cross-linking and causing osmotic lysis in Population YY. Population XX is unharmed because animal cells lack cell walls and do not synthesize peptidoglycan.

NEXT STEPS
Final Takeaways from Your Teacher
  • Review the distinct cellular targets of major antibiotic classes, separating cell wall inhibitors (e.g., β\beta-lactams, glycopeptides) from translation inhibitors (e.g., aminoglycosides, macrolides).

  • Practice identifying whether a drug target resides in the cell envelope, ribosome, nucleic acid machinery, or metabolic pathways based on enzyme names.

Lock it in

Similar question

01

A blood smear reveals an organism with a diameter of 1.2  μm1.2\;\mu\text{m} containing circular uncompartmentalized DNA and 16 S16\text{ S} rRNA. Classify this cell as prokaryotic or eukaryotic, and state whether it would possess mitochondria.

Answer

Prokaryotic. It does not possess mitochondria because prokaryotes lack membrane-bound organelles.

02

An isolate of lung fluid reveals oval cells averaging 6  μm6\;\mu\text{m} in diameter containing a membrane-bound nucleus, 18 S18\text{ S} rRNA, and a cell wall composed of chitin and β\beta-glucans. Categorize this organism and state whether penicillin (a transpeptidase inhibitor) would be effective against it.

Answer

Eukaryotic (fungal cell). Penicillin is completely ineffective because fungal walls contain chitin and glucans rather than bacterial peptidoglycan cross-linked by transpeptidase.

03

An antimicrobial peptide binds exclusively to bacterial lipid II and prevents the cross-linking catalyzed by transpeptidase. If applied to a co-culture of Staphylococcus aureus and human chondrocytes, predict the viability of each cell type and explain the biochemical basis.

Answer

Staphylococcus aureus will undergo cell lysis and die, while human chondrocytes remain fully viable. The biochemical basis is selective toxicity: human cells lack lipid II and a peptidoglycan cell wall entirely, so the drug has no target in host cells.

Loading workspace…